Evidensia Djursjukvård AB
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Evidensia Djursjukvård AB - overview
Established
2012
Location
Stockholm, -, Sweden
Primary Industry
Healthcare
About
Based in Sweden, Evidensia Djursjukvård AB operates as a leading provider of veterinary care and animal health services, delivering essential medical attention to pets across the country through a network of clinics. Evidensia Djursjukvård AB specializes in veterinary care, addressing the health needs of pets. Founded in 2012 and headquartered in Stockholm, Sweden, the company has undergone significant changes, including a merger with Independent Vetcare Limited in 2017, creating IVC Evidensia, the largest veterinary group in Europe. The company was founded by Olof Skarman, who has a history of involvement in the veterinary sector.
Since its inception, Evidensia has completed a total of 3 deals, with the most recent occurring on February 23, 2017. Evidensia offers a wide range of veterinary care services, focusing on the health and well-being of pets, including dogs, cats, and small animals. Their offerings include routine vaccinations, advanced surgical procedures, diagnostics, and rehabilitation. The company has developed a mobile application that provides telemedicine consultations, allowing pet owners to access veterinary advice remotely, thus broadening their service delivery.
Evidensia is committed to providing high-quality veterinary services at various clinics throughout Sweden. In the most recent fiscal year of 2024, Evidensia reported a revenue of USD 4,333. 54 mn and an EBITDA of USD 751. 37 mn.
Their revenue is primarily generated through direct-to-consumer transactions, encompassing fees for in-clinic services, telemedicine consultations, and specialized treatment packages, alongside partnerships with other veterinary practices to enhance their service offerings. Evidensia Djursjukvård AB continues to implement its growth strategy following the merger that took place in June 2017, which expanded its operational footprint across Europe. The company is focused on product innovation, with plans to introduce new veterinary solutions and enhance its telemedicine offerings. Furthermore, Evidensia aims to expand into additional European markets, with specific targets set for the coming years.
The proceeds from the 2017 merger will support these initiatives, ensuring that the company can leverage its larger scale to improve service delivery and meet the evolving needs of pet owners.
Current Investors
EQT, Intera Partners, IVC Evidensia
Primary Industry
Healthcare
Sub Industries
Consumer Services, Hospitals, Clinics/Outpatient Services, Dental Products & Services
Website
www.evidensia.se
Verticals
Mobile Apps
Company Stage
Merged
Total Amount Raised
Subscriber access only
Evidensia Djursjukvård AB - timeline of key events

Evidensia Djursjukvård AB - financials
| Fiscal Year Ended | Sep 30, 2017 | Sep 30, 2018 | Sep 30, 2019 | Sep 30, 2020 | Sep 30, 2021 | Sep 30, 2022 | Sep 30, 2023 | Sep 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 3,863,199.354 | 1,640,942.793 | 2,473,578.5 | 3,169,086.773 | 7,239,137.695 | - | - | - |
| % Revenue Growth (YoY) | - | (57.5%) | 50.7% | 28.1% | 128.4% | - | - | - |
| EBITDA (USD) | (1,072,081.681) | (2,469,721.211) | (420,807.178) | (1,357,622.354) | (23,783,887.023) | - | - | - |
| Operating Income (USD) | (1,120,764.593) | (2,551,304.906) | (591,520.712) | (1,726,991.985) | (24,625,459.628) | - | - | - |
| Operating Margin | (29.0%) | (155.5%) | (23.9%) | (54.5%) | (340.2%) | - | - | - |
| % EBITDA Margin | (27.8%) | (150.5%) | (17.0%) | (42.8%) | (328.5%) | - | - | - |
| NET Income (USD) | (8,746,946.047) | (7,825,913.785) | 1,618,579.799 | (559,577.963) | (26,320,876.162) | - | - | - |
| % Net Margin | (226.4%) | (476.9%) | 65.4% | (17.7%) | (363.6%) | - | - | - |
Evidensia Djursjukvård AB - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Secondary Buyout | Completed | IVC Evidensia | - | ||||||||
| Trade Sale | Completed | IVC Evidensia | - | ||||||||
| Merger | Completed | Evidensia Djursjukvård AB, Independent Vetcare Limited | - | ||||||||
| Growth | Completed | Evidensia Djursjukvård AB | - | ||||||||
| Trade Sale | Completed | Animagi Oy | - |
Displaying 1 - 5 of 6
Evidensia Djursjukvård AB - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.